financetom
ATR
financetom
/
Healthcare
/
ATR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
AptarGroup, Inc.ATR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets.

The company operates through three segments: Aptar Pharma, Aptar Beauty, and Aptar Closures. The company provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions.

It also sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market.

In addition, the company offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets.

The company primarily sells its products and services through its own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America.

AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Latest News >
UniQure Gets Favorable Recommendation From Data Monitoring Committee AMT-162 Trial to Treat Amyotrophic Lateral Sclerosis
UniQure Gets Favorable Recommendation From Data Monitoring Committee AMT-162 Trial to Treat Amyotrophic Lateral Sclerosis
Jan 30, 2025
09:47 AM EST, 01/30/2025 (MT Newswires) -- UniQure ( QURE ) said Thursday the Independent Data Monitoring Committee for a phase 1/2 trial of AMT-162 to treat amyotrophic lateral sclerosis caused by mutations in the superoxide dismutase 1 gene recommended going ahead with enrollment in the second group after reviewing safety data from the first group in the study. The...
US SEC case over massive Allen Stanford fraud ends, judge orders fines
US SEC case over massive Allen Stanford fraud ends, judge orders fines
Jan 30, 2025
* Convicted financier ordered to pay $5.9 billion fine * Fake CDs used in Ponzi scheme * Stanford serving 110-year prison term By Jonathan Stempel Jan 30 (Reuters) - A federal judge ordered an end to the U.S. Securities and Exchange Commission's 16-year-old lawsuit over Allen Stanford's $7.2 billion Ponzi scheme, directing the financier and two former colleagues to pay...
US STOCKS SNAPSHOT-S&P 500, Nasdaq open higher as markets assess barrage of earnings
US STOCKS SNAPSHOT-S&P 500, Nasdaq open higher as markets assess barrage of earnings
Jan 30, 2025
Jan 30 (Reuters) - The S&P 500 and the Nasdaq opened higher on Thursday, driven by post-earnings gains in Meta and Tesla, while Microsoft's lackluster cloud forecast and downbeat results from Cigna tempered overall market optimism somewhat. The Dow Jones Industrial Average fell 164.8 points, or 0.37%, at the open to 44,548.69. The S&P 500 rose 11.4 points, or 0.19%,...
Washington DC airspace challenges highlighted by passenger jet and Army helicopter collision
Washington DC airspace challenges highlighted by passenger jet and Army helicopter collision
Jan 30, 2025
* Congested airspace over Washington DC poses safety risks * FAA audit targets runway incursion risks at busiest U.S. airports * Army and Defense Department launch investigation into collision * Reagan is the 24th-busiest U.S. airport by passengers (Adds graphics links) By David Shepardson ARLINGTON, Virginia, Jan 30 (Reuters) - The crash of an American Airlines ( AAL ) passenger...
Copyright 2023-2026 - www.financetom.com All Rights Reserved